Indolent Systemic Mastocytosis

general

An indolent mast cell neoplasm characterized by systemic infiltration of skin and internal organs by aggregates of neoplastic mast cells. There is no evidence of mast cell leukemia or clonal hematologic malignancy. Clinically, there is no evidence of palpable hepatomegaly and splenomegaly, malabsorption syndrome, or pathologic fractures.

Centers

Active Trials

$316M

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Bone Marrow Mastocytosis	9	9

Top Centers for Indolent Systemic Mastocytosis(21)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	66.8
2	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	3	—	66.8
3	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	3	—	66.8
4	Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program	Active Research Program	2	—	66.8
5	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	2	—	66.8
6	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	3	—	66.8
7	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	3	—	66.8
8	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	2	—	44.3
9	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	44.3
10	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	44.3
11	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	1	—	44.3
12	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program	Active Research Program	1	—	44.3
13	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	44.3
14	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	1	—	44.3
15	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	2	—	44.3
16	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	2	—	44.3
17	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	1	—	44.3
18	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	1	—	44.3
19	University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program	Active Research Program	1	—	44.3
20	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive		1	$186M	—
21	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive		1	$130M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →